Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Tesamorelin, a growth hormone-releasing factor (GHRF) analog, stimulates natural GH production, specifically targeting visceral fat reduction and improved lipid profiles
Obesity Disease Burden and Population Health ROI Framework Economic Cost of Obesity, Comorbidity Cascade, and GLP-1 Pharmacotherapy Value-Based Evidence Reshape Global Treatment Investment The Global Obesity Forum estimated total annual economic costs of obesity at USD 4.32 trillion annually in 2025 , representing 2.92% of global GDP and exceeding the full economic output of Germany
Most Insurance Accepted
As weight decreases and the body adapts, the overall effect on weight can become less pronounced, even if appetite remains controlled
US$ 20.05
US$ 20.68
US$ 24.06
US$ 20.53
US$ 28.33
US$ 26.57
